Nearly 30 million U.S. adults still take aspirin daily to prevent heart disease, many without medical advice, despite ...

Zetia keeps your body from absorbing cholesterol in your diet, and it is generally safe and well-tolerated. So, it’s a good ...

Aspire Biopharma Holdings, Inc., Announces Last Patient Dosed in Phase 1 Clinical Trial of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation ACCESS Newswire Updated June 24, 2025 8:41 AM ...

ESTERO, FL AND NEW YORK, NY / ACCESS Newswire / June 24, ... Phase 1 Study Design. ... (approximately two 81 mg aspirin tablets).

ESTERO, FL AND NEW YORK, NY / ACCESS Newswire / June 24, ... Phase 1 Study Design. ... (approximately two 81 mg aspirin tablets).

Enrollment Completed on Schedule; Topline Results Expected Mid Q3 2025 ESTERO, FL AND NEW YORK, NY / ACCESS Newswire / June 24, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or ...

Aspire Biopharma enrolls last patient in phase 1 trial of its oral transmucosal fast-acting high-dose aspirin formulation: Estero, Florida Thursday, June 26, 2025, 18:00 Hrs [IST] ...

ESTERO, FL AND NEW YORK, NY / ACCESS Newswire / June 24, ... Phase 1 Study Design. ... (approximately two 81 mg aspirin tablets).

ESTERO, FL AND NEW YORK, NY / ACCESS Newswire / June 24, ... Phase 1 Study Design. ... (approximately two 81 mg aspirin tablets).

ESTERO, FL AND NEW YORK, NY / ACCESS Newswire / June 24, ... Phase 1 Study Design. ... (approximately two 81 mg aspirin tablets).

ESTERO, FL AND NEW YORK, NY / ACCESS Newswire / June 24, ... Phase 1 Study Design. ... (approximately two 81 mg aspirin tablets).